The effect of intensive glucose control on major kidney outcomes in type 2 diabetes remains unclear. To study this, the ADVANCE trial randomly assigned 11,140 participants to an intensive glucose-lowering strategy (hemoglobin A1c target 6.5% or less) or standard glucose control. Treatment effects on end-stage renal disease ((ESRD), requirement for dialysis or renal transplantation), total kidney events, renal death, doubling of creatinine to above 200 μmol/l, new-onset macroalbuminuria or mic...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Intensive glucose control improves kidney outcomes in patients with type 2 diabetes.
If you are the owner of this record, you can report an update to it here: Report update to this record